(Q45749140)

15 December 2017

title

Detection of the selective androgen receptor modulator S-4 (Andarine) in a doping control sample (English)

1 reference

15 December 2017

author name string

Borislav Starcevic

series ordinal

1

1 reference

15 December 2017

Brian D Ahrens

series ordinal

2

1 reference

15 December 2017

Anthony W Butch

series ordinal

3

1 reference

15 December 2017

language of work or name

1 reference

21 February 2013

1 reference

15 December 2017

Drug Testing and Analysis

published in

1 reference

15 December 2017

volume

5

1 reference

15 December 2017

issue

5

1 reference

15 December 2017

page(s)

377-379

1 reference

15 December 2017

Selective androgen receptor modulators as function promoting therapies

cites work

1 reference

Recent developments in antiandrogens and selective androgen receptor modulators

21 January 2018

1 reference

Comparison of the pharmacological effects of a novel selective androgen receptor modulator, the 5alpha-reductase inhibitor finasteride, and the antiandrogen hydroxyflutamide in intact rats: new approach for benign prostate hyperplasia.

21 January 2018

1 reference

Selective androgen receptor modulator treatment improves muscle strength and body composition and prevents bone loss in orchidectomized rats

21 January 2018

1 reference

Drug insight: Testosterone and selective androgen receptor modulators as anabolic therapies for chronic illness and aging

21 January 2018

1 reference

Detection of the arylpropionamide-derived selective androgen receptor modulator (SARM) S-4 (Andarine) in a black-market product

21 January 2018

1 reference

Mass spectrometric characterization of urinary metabolites of the selective androgen receptor modulator S-22 to identify potential targets for routine doping controls

21 January 2018

1 reference

The selective androgen receptor modulator GTx-024 (enobosarm) improves lean body mass and physical function in healthy elderly men and postmenopausal women: results of a double-blind, placebo-controlled phase II trial.

21 January 2018

1 reference

Mass spectrometry of selective androgen receptor modulators

21 January 2018

1 reference

Aryl-propionamide-derived selective androgen receptor modulators: liquid chromatography-tandem mass spectrometry characterization of the in vitro synthesized metabolites for doping control purposes

21 January 2018

1 reference

Sensitive determination of prohibited drugs in dried blood spots (DBS) for doping controls by means of a benchtop quadrupole/Orbitrap mass spectrometer

21 January 2018

1 reference

Doping control analysis of tricyclic tetrahydroquinoline-derived selective androgen receptor modulators using liquid chromatography/electrospray ionization tandem mass spectrometry

21 January 2018

1 reference

RSR13, a potential athletic performance enhancement agent: detection in urine by gas chromatography/mass spectrometry

21 January 2018

1 reference

Mass spectrometric characterization of urinary metabolites of the selective androgen receptor modulator andarine (S-4) for routine doping control purposes

21 January 2018

1 reference

Selective androgen receptor modulators in preclinical and clinical development

21 January 2018

1 reference

7 January 2021

High-throughput screening for various classes of doping agents using a new 'dilute-and-shoot' liquid chromatography-tandem mass spectrometry multi-target approach

1 reference

7 January 2021

SARM-S4 and metabolites detection in sports drug testing: a case report

1 reference

7 January 2021

Detection of prohibited substances by liquid chromatography tandem mass spectrometry for sports doping control

1 reference

7 January 2021

Identifiers

DOI

10.1002/DTA.1466

1 reference

15 December 2017

1 reference

15 December 2017